| Dr Janis A Pastena, MD | |
|
100 Woods Road, Nymc Dept. Of Surgery, Munger Pavilion, Valhalla, NY 10595 | |
| (914) 261-7319 | |
| (914) 593-1802 |
| Full Name | Dr Janis A Pastena |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 100 Woods Road, Valhalla, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013095694 | NPI | - | NPPES |
| 01223752 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 146287 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Janis A Pastena, MD 100 Woods Road, Nymc Dept. Of Surgery, Munger Pavilion, Valhalla, NY 10595 Ph: (914) 261-7319 | Dr Janis A Pastena, MD 100 Woods Road, Nymc Dept. Of Surgery, Munger Pavilion, Valhalla, NY 10595 Ph: (914) 261-7319 |
News Archive
Each year, only five percent of the estimated 1.5 million children with an autism spectrum disorder in the US participate in clinical research studies. This is in stark contrast to pediatric cancer studies, which have a nearly 90 percent enrollment rate - a rate that has helped advance treatment and outcomes for childhood cancers substantially in the last decade.
Austin Retina Associates has joined with the Macula Vision Research Foundation (MVRF) to sponsor a SupportSight seminar in Austin on October 3rd. SupportSight is the national series of educational seminars for people affected by macular degeneration and for those who would like to learn more about this disease affecting more than 25 million people in this country.
New research on gene expression provides a breakthrough in breast cancer treatment. Women who have triple-negative breast cancer are a small proportion of breast cancer cases, but it is difficult to treat and might have a more aggressive clinical course than other forms of the disease.
An onslaught of mobile health technology has forced an arranged marriage between smartphone app makers and the Food and Drug Administration - because someone had to regulate them. There's just one problem: Many of the tech wizards aren't used to FDA supervision. And now, both sides are struggling to figure out how to live with each other.
Lux Biosciences, Inc. a privately held biotechnology company focused on the treatment of ophthalmic diseases, today announced results from a Phase 1 human safety and an open-label pilot efficacy study of the company's potential best-in-class therapy for dry eye, LX214 (topical mixed nanomicellar formulation of voclosporin).
› Verified 9 days ago
Roberto Jose Arias Gautreaux, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 100 Woods Rd Rm E-130, Valhalla, NY 10595 Phone: 914-493-7614 | |
Gary Gaspare Lombardo, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Taylor Pavilion E-135, Valhalla, NY 10595 Phone: 914-493-5213 Fax: 914-493-5271 | |
Dr. Peter Rhee, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 | |
Daniel Jo, Surgery Medicare: Medicare Enrolled Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7614 | |
Mr. Arlind Decka, MD Surgery Medicare: Medicare Enrolled Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 | |
Dr. Chiaka Ogechi Akarichi, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 |